Spermiation is the final phase of spermatogenesis leading to release of mature spermatids into the lumen of the seminiferous tubules. Morphologically, it involves a series of events, namely removal of excess spermatid cytoplasm, removal of ectoplasmic specialization, formation of tubulobulbar complex, and final disengagement of the spermatid from the Sertoli cell. Previous studies in our laboratory have shown that administration of 17␤-estradiol at a dose of 100 g/kg body weight for 10 d resulted in failure of spermiation. This was accompanied by a suppression of FSH and intratesticular testosterone with a concomitant rise in intratesticular 17␤-estradiol. The present study was undertaken to determine the cause of failure and subsequently the molecular events in spermiation. Electron microscopic and confocal studies revealed an absence of tubulobulbar complex in step 19 spermatids after estradiol treatment, highlighting the significance of these structures in spermiation. It was further observed that treatment affected the Sertoli cell cytoskeleton and Arp2/3 complex that is critical for de novo polymerization of actin during tubulobulbar complex formation. In conclusion, the present study reports the role of 17␤-estradiol in inhibiting the formation of tubulobulbar complex, which could be one of the mechanism by which environmental estrogens influence male fertility. (Endocrinology 150: 1861-1869, 2009) 
S
permiation is the final step of spermatogenesis leading to the release of the mature step-19 spermatids in the rat seminiferous tubule lumen. Most studies to this date focused on understanding the morphological basis of this process; however, there is little information on molecular events leading to spermiation. Morphologically the process begins with the transport of step 18 spermatids, which lie in the deep recesses of the Sertoli cell cytoplasm in stage VI to a more luminal position in stage VII. Concomitantly there is replacement of ectoplasmic specialization (ES) by tubulobulbar complexes (TBCs) followed by the final disengagement of the spermatid from the Sertoli cell (1) .
The ES is actin-based adheren junctions between the elongating/elongated spermatids and Sertoli cell. The ES occurs within the Sertoli cell, characterized by hexagonally packed actin bundles that are oriented parallel to the Sertoli cell plasma membrane being sandwiched between plasma membrane and cistern of endoplasmic reticulum (2, 3) . TBCs are actin rich, consisting of tubular extensions from the plasma membrane of the spermatid head that protrude into the corresponding plasma membrane of the Sertoli cell. Actin cuffs surround the tubular portion, whereas the proximal region consists of a bulbous swelling devoid of actin surrounded by elements of endoplasmic reticulum and numerous vesicles. It has been suggested that TBCs are devices, which are involved in internalization of junctions by endocytosis (1, 4) .
During spermiation, remodeling of junctions facilitates mutual separation of Sertoli and germ cells. In many cells remodeling and junctional stability is thought to be dependent on the underlying cytoskeletal apparatus, e.g. fish fibroblast microtubules are known to affect the stability of focal adhesions (5) . Primary macrophages and osteoclast have unique and highly dynamic adhesion structures referred as podosomes whose formation is dependent on the microtubule apparatus of the cell (6) . Lately there has been a speculation that TBCs, although specific to the testis, bear a striking resemblance to podosomes because both contain a tubular core surrounded by actin filaments (7) . The involvement of Sertoli cell cytoskeleton in spermiation has been evident from studies by Russell et al. (8) using specific inhibitors to cytoskeletal elements. All these evidences point out to a structure-function relationship that could exist between the ES, TBC, and Sertoli cell cytoskeleton during spermiation.
Studies by Beardsley et al. (9, 10) highlighted the role of cell adhesion molecules in spermiation. Using a hormone suppression model, with suppression of FSH and intratesticular testosterone (iT) it was demonstrated that spermiation failure was caused due to a dysfunction in the final disengagement process mediated by ␣6␤1-integrin and changes in the phosphorylation status of its associated kinase namely focal adhesion kinase.
Our earlier studies showed that 17␤-estradiol treatments also induced failure of spermiation with suppression of FSH, iT, and an increase in intratesticular 17␤-estradiol (iE) (11) . The objective of the present study was to elucidate the cause of spermiation failure and the mechanism involved. In the present study, we observed an absence of TBCs around mature step 19 spermatids. Hence, we next studied the molecules involved in TBC formation. Insights into the molecules involved came from microarray study done on 17␤-estradiol-treated testicular tissues in which we observed a 2-fold down-regulation of p41Arc, a subunit for Arp2/3 complex (Balsinor, N. H., R. D'Souza, S. Thomas, H. Zuping, and M. Dym, unpublished data). Furthermore, studies on A7r5 vascular smooth muscle cells show that focal adhesions are replaced by podosomes under the influence of Arp2/3 complex (12) . The Arp2/3 is a complex of seven subunits (Arp2, Arp3, p41Arc, p34Arc, p21Arc, p16Arc, p20Arc) of which the p41Arc is crucial for stability of the complex and targeting it to membranes (13, 14) . A similar mechanism could be working in the testis in which the existing ES [which has been speculated to be focal adhesion junctions (reviewed in Ref. 15) ] is replaced by TBC involving a localized de novo actin polymerization by Arp2/3 complex.
Using this model, the effects of 17␤-estradiol on TBC formation and the contribution of the Arp2/3 complex and Sertoli cell cytoskeleton were studied.
Materials and Methods

Animals
Male Holtzman rats (75-90 d old) were obtained from the institute's animal house facility. These animals were maintained at 22 C in a fixed 14-h light, 10-h dark cycle with free access to food and water. The institutional animal ethics committee approved the use of animals for the study.
Experimental design and steroid treatment
17␤-Estradiol (Sigma, St. Louis, MO) was administered to adult male rats at a dose of 100 g/kg body weight daily for 10 d. The drug was suspended in saline and administered by sc route as described earlier (11) . Control animals received only saline. This treatment was previously shown to suppress circulating FSH by 50% of control levels and iT levels to 10% of the control levels. In addition there was also a 4-fold increase in iE levels in the treated animals when compared with controls.
Tissue collection
Control and treated animals were grouped into batches with at least three in each batch. For light microscopic studies and immunohistochemistry, animals in batch 1 were perfusion fixed with Bouin's fixative through the heart for 20 min and subsequently processed for paraffin block preparation. For electron microscopy, animals in batch 2 were perfusion fixed with Karnovsky's fixative through the testicular vein for 10 min and processed for electron microscopy. For F-actin and immunofluorescence studies, animals in batch 3 were perfusion fixed with warm (37 C) 4% paraformaldehye prepared in PBS [0.01 M phosphate buffer containing 0.154 NaCl (pH 7.4)] through the heart for 30 min. Stabilized with 30% sucrose, placed in Tissues Tek optimum cutting temperature compound, and snap frozen in liquid nitrogen and stored at Ϫ80 C to be used later for cryosections. For Arp3 and F-actin staining on fragmented material, animals in batch 4 were perfusion fixed with 4% paraformaldehyde as describe above. Testes were processed further to prepare fragmented material containing junctions attached as described by Vaid et al. (7) . In batch 5, after treatment animals were killed, testis were excised, one testis was used for transillumination, and the other testis was frozen in liquid nitrogen and stored at Ϫ80 C for subsequent RNA extraction.
Light microscopy (batch 1)
Five-micrometer sections were taken and stained with hematoxylineosin stain. Stages VII-VIII tubules containing at least one step 19 spermatids in the deep recesses instead of a luminal position were counted. For each animal a total of 10 tubules of stages VII-VIII were examined in the study. Data are expressed as percentage of tubules showing spermatids in the deep recess vs. total number of tubules counted.
Electron microscopy (batch 2)
After perfusion with Karnovsky's fixative, fragments of testicular tissue were postfixed with 1% osmium tetroxide for 60 min at 4 C, dehydrated with acetone series, and cleared in toluene. Epoxy resin infiltration and embedding were carried out with Araldite 502 resin (Pelco International, Clovis, CA). Ultrathin sections were cut from three blocks per animal for both groups, mounted on copper grids, contrasted uranyl acetate in 50% (vol/vol) ethanol and 0.83% (wt/vol) lead citrate in distilled water, and viewed under a TecnaiG 2 -12 transmission electron microscope (Fei, Eindhoven, The Netherlands) at an accelerating voltage of 80 kV. Electron micrographs were captured using a Mega View III (Soft Imaging System, Munster, Germany) charge-coupled device camera. 
Antibodies
F-actin staining (batch 3)
Eight-micrometer cryosections were post fixed with chilled acetone (Ϫ20 C) for 10 min and subsequently equilibrated in PBS and blocked with Image-iTFX signal enhancer (Molecular Probes, Eugene, OR) for 30 min. This was followed by incubating in staining solution-containing BodipyFL-labeled Phallodin (Molecular Probes) at 1:40 dilution from a methanolic stock of 6.6 M and propidium iodide (PI) (Calbiochem) as a counterstain. After incubation for 20 min, the sections were washed with PBS and mounted in Prolong Gold Antifade (Molecular Probes).
Immunofluorescence (batch 3)
Frozen sections were postfixed as described above, equilibrated in PBS, and permeabilized with 0.1% Triton X-100 (Sigma) for 10 min. The sections were blocked with iTFX signal enhancer and incubated in respective primary antibody viz. Arp3 or ␤-tubulin overnight at 4 C. Sections were washed in PBS and treated with secondary antibody goat antimouse labeled with Alexafluor488 (Molecular Probes). Sections were counterstained with PI and mounted in Prolong Gold Antifade (Molecular Probes). In case of vinculin and Arp3, an additional antigen retrieval step with antigen retrieval solution (Vector Laboratories, Burlingame, CA) was done. The negative controls contained normal mouse IgG at equivalent concentration as that of primary antibody. In the case of colocalization studies for Arp3 and F-actin on fragmented material or ␤-tubulin and F-actin, both Arp3 and ␤-Tubulin were detected using goat antimouse labeled with Alexafluor488 (green), whereas F-actin was detected using phalloidin labeled with Bodipy558/568 (red) (Molecular Probes). 4Ј,6Ј-Diamidino-2-phenylindole (DAPI; Calbiochem) was used as a counterstain at a concentration of 300 nM and mounted in Prolong Gold Antifade (Molecular Probes). Ten tubules per stage per animal were examined.
Confocal microscopy and colocalization studies
Fluorescent images were captured using the LSM510-Meta confocal system (Carl Zeiss, Jena, Germany). Z stacks were taken and a threedimensional composite image was generated. For double staining, the multitrack option was used to eliminate cross talk of chromophores and ensure reliable colocalization. For colocalization the Zeiss LSM software version 4 was used. The threshold levels were set by selecting a region outside the zone of interest; this helps in eliminating the background fluorescence and fixes the cross-hair function. A region of interest is then selected to determine colocalization. A cut-mask image was generated, which represents only colocalized areas. In the scatter diagram, region 1 represents pixels in channel 1 only, region 2 represents pixels in channel 2 only, whereas region 3 represents colocalizing pixels; lastly region 4 represents subthreshold pixels or background intensities.
Western blotting (batch 5)
The testis was detunicated, seminiferous, and tubules were teased in PBS and examined under transillumination stereomicroscope. Stages VII-VIII were identified as a dark zone as described by Parvinen and Roukonen (16) . Five-millimeter fragments were pooled and snap frozen in liquid nitrogen. Protein was extracted in radioimmunoprecipitation assay lysis buffer [150 mM NaCl, 50 mM Tris (pH 7.5), 5 mM EDTA, 1% Nonidet P-40, 1% deoxycholic acid, 10% sodium dodecyl sulfate] containing protease inhibitors. Then 40 g of protein were resolved on 12% SDS-PAGE and transferred onto nitrocellulose membrane (Amersham, Buckinhamshire, UK). The blots were washed with PBS, blocked with 5% nonfat dry milk and incubated with a mixture of primary antibodies namely Arp3 and GAPDH in 5% nonfat dry milk at 4 C overnight. The membranes were washed with 0.01 M PBS containing 0.1% Tween 20 and incubated with secondary goat antimouse horseradish peroxidase labeled (Sigma), developed with ECL Plus reagent (Amersham). The bands were visualized and quantitated by densitometry.
Quantitative real-time PCR (batch 5)
Testicular RNA was extracted using Trizol (Invitrogen, Carlsbad, CA). The RNA was deoxyribonuclease treated and cDNA was synthesized using reverse transcriptase system and oligo-deoxythymidine primers (Promega, Madison, WI). One microliter of cDNA was mixed with SYBR green master mix in a 25-l reaction (Bio-Rad, Hercules, CA). Primers for p41Arc and L19 (housekeeping gene) were generated using Primer 3 software Whitehead Institute for Biomedical Research, Cambridge, MA; http://fokker.wit. mit.edu/cgi-bin/primer3/primer3_www.cgi; Ref. (29) the sequence of which is as follows: p41Arc, forward, cagtcaaatctcggtgctca, reverse, attcagcaaagcagccctta; L19 forward, GAAATCGCCAATGCCAACTC, reverse, AC-CTTCAGGTACAGGCTGTG. Standard curves were prepared from serially diluted cDNA to check the efficiency of the reaction. Because the efficiency was the same for both genes, the fold change was determined using the 2 -⌬⌬CT method. Each sample was run in triplicate. Melt curve analysis was done to check for the presence of a single PCR product.
Immunohistochemistry for integrin-␣6␤1 (batch 1)
Five-micrometer sections were taken deparaffinized and rehydrated. Antigen retrieval was done. Sections were blocked with 5% normal goat serum (Vector Laboratories) and incubated with anti-␣6␤1-integrin antibodies overnight at 4 C. The sections were incubated with biotinylated goat antimouse antibody for 60 min at room temperature, followed by incubation with streptavidin conjugated with horseradish peroxidase (Santa Cruz Biotechnology, Santa Cruz, CA) with suitable washes with PBS at every step. Detection was done using diaminobenzidene and H 2 O 2 counterstained with hematoxylin. For negative controls an equivalent amount of normal mouse IgG was used. Ten tubules per stage per animal were examined.
Statistical analysis
The statistical analysis was performed using unpaired students t test using GraphPad Prism (version 4; GraphPad Inc., San Diego, CA). The level of significance was set at P Ͻ 0.05.
Results
17␤-Estradiol treatment affects stages VII-IX of spermatogenesis
In the seminiferous tubules of control rat, before sperm release in stage-VI, the heads of the step 18 spermatids were deeply embedded in the apical crypts (Fig. 1A) . In stage VII, the spermatid head gets noticeably sickle shaped (step 19 spermatids) and moves toward the luminal edge of the tubules (Fig. 1B) . By stage VIII, all the spermatids have lined the luminal edge and are ready to be released (Fig. 1C) . In stage IX almost all the step 19 spermatids have been released (Fig. 1D) .
In the treated testis, stage VI showed step 18 spermatids in the deep apical crypts as seen in the controls (Fig. 1E) . Stage VII tubules showed spermatids at varying levels; some appear in the deep recess, whereas few attained a normal luminal position, and some spermatids were seen at the base of the seminiferous epithelium. Those present at the base represent the spermatids, which are phagocytosed by the Sertoli cell (Fig. 1, F and G). The tubules with at least a single step 19 spermatid in deep recess in stages VII-VIII were counted. In the treated samples, 77.5 Ϯ 8.5% (mean Ϯ SE) tubules showed such spermatid vs. 6.6 Ϯ 3.3% (mean Ϯ SE) in controls, which was significantly higher (P Ͻ 0.05). Moreover, the numbers of spermatids in the deep recesses in stage VII were comparatively more in the treated tubules compared with the control tubules. Spermatids that failed to be released in stage VIII are subsequently phagocytosed by the Sertoli cell and seen as hook shaped structures in seminiferous epithelium of stage IX as reported earlier (Fig. 1H) (11) .
Electron microscopy (EM) reveals absence of TBCs around step 19 spermatids
Step 19 spermatids in stage VII were examined by electron microscopy. The identity of the stage VII tubules chosen for EM was confirmed by presence of step 7 spermatids identified by characteristic 140 0 acrosome spread over the nucleus and the presence of the small flagellum, which contacted the nucleus (Fig.  1iv) . In controls, step 19 spermatids showed the presence of tubular extension, which were identified as TBCs (Fig. 1i) . At the distal end of tubular extension, clusters of vesicles were ob-served. Treated sample showed two characteristic phenotypes, a common feature; however, in both phenotypes observed was the absence of TBC in spermatids. In the first phenotype, we observed step 19 spermatid with a well-defined ES (Fig. 1ii) . In the second phenotype, we observed step 19 spermatid with ES on the lower surface, but the ES appeared disrupted on the upper surface of the spermatid (Fig. 1iii) . Prominently absent were the vesicular structures in all spermatids examined. Interestingly, the presence of spermatid heads and tails deeply embedded in Sertoli cell cytoplasm in which normally only round spermatids are seen was observed (supplemental Fig. 1 , published as supplemental data on The Endocrine Society's Journals Online web site at http://endo.endojournals.org). This confirmed our light microscopic examination, which show spermatids that fail to move to the luminal edge eventually got phagocytosed.
F-Actin staining in stages VII-VIII of spermatogenesis
Because EM studies indicated the absence of TBC, this was confirmed by studying the distribution of F-actin, a well-characterized marker for both ES and TBC. In control stage VII, F-actin staining around step 19 spermatids showed a weak signal on the dorsal or convex surface of the head compared with a strong positive signal in the concave or ventral side (Fig. 2B) . This positive signal was visualized as narrow tubular evaginations, which were identified as TBCs. (Fig. 2B, inset) . In treated stage VII, no tubular evaginations were seen around step 19 spermatids, indicating the absence of TBCs (Fig. 2D) . However, in a few spermatids, ES was seen around the spermatid head, especially those apical in position (Fig. 2D, inset) . Overall, the F-actin appeared filamentous and disorganized. No positive staining was observed in spermatids, which were present at the base of the epithelium in stage VII. In stage IX no positive staining was seen around the failed spermatids; however, staining around the elongating spermatids appeared fainter compared with controls (Fig.  2, F and H, and supplemental Fig. 2a) . The F-actin staining in other stages appeared normal (supplemental Fig. 2b) . 
Vinculin staining seen around failed spermatids
Vinculin serves to link the F-actin to the membrane molecules (17) . In stages VII-VIII, positive vinculin staining was seen in regions associated with TBCs at contacts between adjacent Sertoli cells and around the spermatogonia (Fig. 2J) . In the treated samples positive vinculin staining was seen at the base; however, staining around the step 19 spermatids appeared diffused and disorganized, reflecting the disorganization seen in the F-actin. In control stage IX, vinculin staining was seen around the luminal margins of the epithelium (Fig. 2N ) and also around luminally placed failed spermatid (Fig. 2P) . A faint nonspecific staining was occasionally seen in the interstitial regions of the testis in negative control.
Stage-specific localization of Arp3 during spermatogenesis
To test the hypothesis that Arp2/3 complex is responsible for TBC formation, we studied the stage-specific expression of one of the subunits of this complex namely Arp3. Interestingly, Arp3 was localized only in stage VII of spermatogenesis in which TBC formation occurs with a marked absence in other stages of spermatogenesis. The localization was observed in the concavity of step 19 spermatids as tubular projections reminiscent of TBCs ( Fig. 3B ; for other stages refer to supplemental Fig. 3 ). In the treated samples, an absence or minimal amount of staining in the concavity of step 19 spermatids was observed (Fig. 3D) . This is the first report to study the stagespecific expression of Arp3 in the testis. It is also noteworthy to mention that TBCs are sites rich in G-actin, as observed by using Alexafluor488-labeled deoxyribonuclease as a probe for G-actin, further suggesting that these are areas of rapid turnover and de novo polymerization of actin (supplemental Fig. 4, A-F ).
Arp2/3 is localized at tubulobulbar complexes
To confirm that Arp3 was present at TBCs, colocalization with F-actin was done. This was not possible on testicular section because antigen retrieval was performed and this procedure destroys phalloidin binding to F-actin. Hence, colocalization was done on fragmented testicular material in which the junctions remain intact on spermatids. Arp3 colocalized with F-actin at TBCs on step 19 spermatids, which were identified as hooked shaped structures with maximal curvature (Fig. 3IV) . The cross-hair function indicated all the green pixels (Arp) colocalized with the red (F-actin) ; however, the reverse was not true (Fig. 3V) . This was because only F-actin was localized on the dorsal surface of the step 19 spermatid head. A cut-mask image represented only the colocalized regions (Fig. 3VI) . In step 19 spermatids obtained from treated animals, no Arp3 staining in majority of spermatids was observed (Fig. 3, b and d) . The cross-hair function indicated pixels only in the red channel for F-actin, suggesting a partial presence of F-actin, which represents the ES that is retained on the treated step 19 spermatid (Fig. 3, c and e) . This also confirmed our EM and F-actin staining, which showed that the ES is retained on few step 19 spermatids in the treated group, especially those that are luminally placed as shown in Fig. 2C (inset) . Occasionally a few treated step 19 spermatids examined showed minimal staining for Arp 3 in their concavity; however, the tubular architecture seen in control was absent. In contrast, some spermatid showed a total absence of both F-actin and Arp3 staining (supplemental Fig. 4, I-IV) .
Western blot analysis for Arp3 and real-time PCR analysis for p41 Arc
Absence or minimal staining of Arp3 observed on step 19 spermatids in the treated group suggested a decrease in Arp3 protein levels. To quantify the decrease, Western blot analysis was done from proteins extracted from stage VII tubules. Surprisingly, no change was observed in the Arp3 expression in control and treated samples (Fig. 4A) , suggesting that there could The down-regulation of the p41Arc subunit of the Arp2/3 complex observed in the microarray experiment was confirmed by real-time RT PCR. A 2.5-fold decrease in expression was observed (Fig. 4B ).
Microtubules and tubulobulbar complex share a close spatial relationship
In macrophages, podosome formation is dependent on an intact microtubule network (6) . It can thus be speculated that microtubules may be involved in TBC formation. To test this hypothesis, stage-specific distribution of microtubules was studied using ␤-tubulin as a marker. We observed a stage-specific effect of treatment with stages VII and VIII being affected. Confocal studies revealed that in control stage VII microtubules have a tree-like appearance, with the basal region representing the trunk exhibiting intense fluorescence, whereas at the luminal edge, there seem to be fine fibrillar branches, which made contact with the ventral concavity of step 19 spermatids (Fig. 5B) . In the treated stage VII, a disruption of the normal microtubular architecture, i.e. the trunk-like appearance was lost for loosely arranged fibers and staining around the step 19 spermatids appeared diffused. The staining, however, appeared more intense at the luminal edge compared with that seen in the basal regions in the treated samples (Fig. 5D) . In stage IX both the control and treated showed similar staining patterns around heads of elongating spermatids. No positive staining was seen around the failed spermatids (Fig. 5, F and H) . Interestingly, in other stages of spermatogenesis, microtubule distribution in treated samples was normal compared with the control (supplemental Fig. 5 ). To confirm that microtubules make actual contact with TBCs, dual staining for microtubules (green) and F-actin (red) was done. We observed a close spatial relationship between the TBCs and microtubules (Fig. 5, IV) . This was confirmed by the cut-mask image generated, which shows only colocalized regions (Fig. 5, V and VI). In the treated samples, colocalization between microtubules and F-actin was markedly reduced and microtubules appeared disrupted, with marginal F-actin staining around the step 19 spermatids (Fig. 5, a-f ).
␣6␤1-Integrin seen around failed spermatids
Immunohistochemical studies revealed positive integrin staining around the head of step 19 spermatids on both ventral and dorsal surfaces of the spermatids heads (Fig. 6A) . The spermatids that did not move to the luminal edge in stage VII in treated showed positive staining, which was diminished in those spermatids, which were phagocytosed and moved to the base (Fig. 6B) . The retained spermatids in stage IX, which were luminally placed, showed significant positive staining (Fig. 6D) .
Discussion
Spermiation accounts for progressive removal of ES, formation of TBCs, and final disengagement (18) . To date, to our knowledge studies done by Beardsley et al. (9, 10) and Saito et al. (19) have been the only reports that have studied the molecular events in spermiation by inducing failure of spermiation.
A striking difference in our present observation vs. those reported by Beardsley et al. (9) was the absence of TBCs, suggesting an independent mechanism for failure of spermiation in our study. This could be due to high iE observed only in our study, whereas iT and FSH were suppressed in both studies, suggesting a direct effect of estradiol on spermiation.
We next analyzed the molecular players involved in TBC formation and the potential influence of high 17␤-estradiol on them. Our studies revealed that Arp3 was specifically localized in stage VII in which TBC formation is initiated and highlighted the crucial role played by this complex in reorganizing the actin cytoskeleton during TBC formation. Further evidence for actin reorganization during TBC formation came from the presence G-actin observed in these regions, suggesting a need for a constant pool of G-actin for de novo polymerization of branched actin. The absence of Arp3 staining in stage VIII suggests that in this stage no new TBC formation occurs just before spermiation. The absence of positive Arp3 staining seen in a majority of step 19 spermatids from the treated group suggested a probable down-regulation of this protein, which affected the normal TBC formation. The amount of down-regulation was quantified; however, no change in the amount of Arp3 protein was observed.
To explain this discrepancy, we turned to studies with A7r5 vascular smooth muscle cells. In this system, proper targeting of the Arp2/3 complex to sites of podosome formation is critical to the formation of podosomes (12) . Given the fact that a few spermatids in the treated group show minimal Arp3 staining, we hypothesized that defective targeting of this complex could have affected TBC formation.
The p41Arc subunit of the Arp2/3 complex is responsible stability and targeting of the complex to the membrane. This is mediated by the binding of the WD domains of this subunit to either the pleckstrin homology domains found in cytoskeletal proteins or phosphatidyl inositol 4,5-bisphosphate found in membranes (13) . It can be speculated that the down-regulation of the p41Arc subunit observed in the present study could result in an apparent inability to target the entire complex to sites of TBC formation. The 17␤-estradiol-mediated direct effect on p41Arc gene expression was verified by presence of estrogen-responsive elements (EREs) in the promoter region. In silico analysis was done to identify a region 4000 bp upstream and 1000 bp downstream from the transcription start site as the promoter region using Promoser, an online tool (20) . The presence of ERE in the promoter sequence was done using the Alibaba version 2 online software, which is based on the TRANSFAC database (21) . Eleven EREs were identified on the promoter, suggesting a direct influence of 17␤-estradiol on regulating the Arp2/3 complex.
Further influence of estradiol on actin organization came from studies done by Anahara et al. (22) , who have shown a decrease in Cortactin staining around the heads of step 19 spermatids after 17␤-estradiol and Bisphenol A treatment. Cortactin is an actin binding protein, which is known to be involved in the polymerization and reorganization of actin. When activated, it is known to recruit the Arp2/3 complex. Furthermore, Dspd mice, which harbor a mutation for the cortactin gene, show retention of step 16 spermatids, which failed to move to the luminal edge (23) . However, these studies have not examined the role of cortactin in TBC formation. Both mechanisms, namely the effect of 17␤-estradiol on Arp2/3 complex or on cortactin (22) , could be working synergistically to affect TBC formation.
The contribution of the Sertoli cell cytoskeleton on TBC formation and spermiation was analyzed. We speculated that microtubules might be involved in aiding TBC formation rather than the final process of sperm release. In support of this, we observed a spatial relationship between microtubules and TBCs. Moreover, the disruption of microtubules specifically in stage VII, suggest a dependence of TBC formation on intact microtubules. As an outcome of this association, it can be speculated that microtubules may be involved in transport of material that could have an influence on TBC formation and actin reorganization. Further evidence suggesting the same comes from two studies, one with podosomes and microtubules in which microtubules are involved in the correct positioning of Wiskott-Aldrich Syndrome Protein (WASP), a key regulator of podosome formation (6) . Wiskott-Aldrich Syndrome Protein (WASP) in turn is known to activate the Arp2/3 (24) . Furthermore, immunoprecipitation studies also show that ␣-tubulin indeed associates with WASP in rat testis (25) . Another evidence in support of our claim came from studies in which stage-specific disruption of microtubules in stage VII, due to overexpression of ␥-tubulin in the seminiferous epithelium, leads to presence of failed spermatids in stage IX (26) , thus giving credence to the claim that microtubules may be required for normal spermiation and TBC formation.
The stage-specific disruption of microtubules could be explained from the fact there exist testosterone and estradiol binding sites on ␤-tubulin (27) . Testosterone inhibited microtubule depolymerization, whereas estradiol only modifies polymerization process and by itself did not cause depolymerization (28) . In the present study, the suppression of iT and increase of iE could have mediated the disruption of the normal microtubular network by affecting the dynamics of microtubule polymerization/ depolymerization and shifting the equilibrium toward depolymerization. The stage specificity of the effect could be attributed to the probable stage-specific expression of microtubule-associated proteins, which are differentially regulated by steroids (28) .
It has been proposed that TBCs are involved in the disassembly and recycling of junctional molecules (4) . It can thus be hypothesized that an inability to form TBCs would result in an inability to remove the Sertoli cell membranes and associated cell adhesion molecules that exist around the mature spermatids. We confirmed the same by observing a retention ␣6␤1-integrin and vinculin around the failed step 19 spermatids. The absence of endocytic vesicles further indicated that the recycling of adhesion molecules was affected. Further evidences in support of this hypothesis came from studies when estradiol treatment was prolonged for 20 d. Morphologically this treatment resulted in the presence of step 19 spermatids, which fail to move toward the lumen in stage VII and failed spermiation but also in the depletion of elongating spermatids in stage IX (supplemental Fig. 6A ). This depletion of elongating spermatids was not previously observed in animals treated for the 10 d. The apparent cause for depletion of elongating spermatids could be attributed to the absence of ES on the few step 9 spermatids seen remaining. Phalloidin staining for F-actin confirmed this absence of ES (supplemental Fig. 6B ). Inability to form TBCs resulted in an inability to recycle crucial junctional components, which are critical for the formation of new junctions around the step 9 elongating spermatids in subsequent stage IX. Formation of these junctions are crucial for correct positioning and further maturation of elongating spermatids.
In conclusion, the present study suggest that 17␤-estradiol could have mediated several unique molecular changes affecting TBC formation, leading to failure of spermiation recycling of junctions, which are critical for the progression of spermatogenesis. The study also highlights the potential effects environmental estrogen could possibly have in affecting spermiation and thereby affecting male fertility.
Conclusion
The study highlights the effect of exogenous 17␤-estradiol treatment on spermiation. 
